Adar Poonawalla, CEO of the Serum Institute of India, said on Friday that he expects another COVID19 vaccine produced by his company in India, Covovax, to launch in the first quarter of 2022 in October, suitable for adults and children. As of now individuals below the age of 18 are refrained from the vaccine program and this announcement provides hope for them.
Image Source- Forbes India
He also thanked the government of India for all the support provided to the Serum Institute and said the company has been working hard to expand its Covishield production capacity to meet demand. Mr. Poonawalla met with Home Minister Amit Shah in Parliament and the meeting between the two lasted 30 minutes.